Mark Litzow(@MRLitzow) 's Twitter Profileg
Mark Litzow

@MRLitzow

I am a hematologist, professor of medicine and specialist in blood and marrow transplantation and in the treatment of acute and chronic leukemia

ID:973216285

calendar_today27-11-2012 03:54:16

27 Tweets

591 Followers

31 Following

Mark Litzow(@MRLitzow) 's Twitter Profile Photo

Join us at Acute & Chronic Leukemias: Practical Applications 2023 on Oct. 6-7 in Orlando, FL (or via livestream). This year’s conference features interactive case presentations with panels of experts weighing in on pivotal treatment issues. Register here: tinyurl.com/ykcnhbhh

account_circle
ESH (Haematology)(@ESHaematology) 's Twitter Profile Photo

📣 STARTS IN 1 MONTH!
Don’t delay! REGISTER NOW & join us on May 19-21, 2023 in Berlin 🇩🇪
➡ bit.ly/3JJxkXm
3rd Translational Research Conference:
ACUTE LYMPHOBLASTIC LEUKAEMIA
Chairs: Jan Cools, Dombret Hervé, Adele Fielding, Mark Litzow

📣 #ESHALL2023 STARTS IN 1 MONTH! Don’t delay! REGISTER NOW & join us on May 19-21, 2023 in Berlin 🇩🇪 ➡ bit.ly/3JJxkXm 3rd Translational Research Conference: ACUTE LYMPHOBLASTIC LEUKAEMIA Chairs: @CoolsJn, @DombretHerve, @AdeleKFielding, @MRLitzow #ESHCONFERENCES #LEUsm
account_circle
Mark Litzow(@MRLitzow) 's Twitter Profile Photo

Please consider attending the 3rd Translational Research Conference on ALL in Berlin May 19-21, 2023. Great line up of translational and clinical talks at .

account_circle
Adele Fielding(@AdeleKFielding) 's Twitter Profile Photo

will start shortly. Sad not to be seeing all my wonderful colleagues and friends in person but I think the meeting will be really good despite that

account_circle
Mark Litzow(@MRLitzow) 's Twitter Profile Photo

Randomizes trial reported at ASCO shows benefit of early integrated palliative care for patients undergoing induction chemotherapy for AML!
meetinglibrary.asco.org/record/186130/…

account_circle
Mark Litzow(@MRLitzow) 's Twitter Profile Photo

via @NYTimes, interesting article on unreliability of many antibody tests for SARS-COV-2. nytimes.com/2020/04/24/hea…

account_circle
Mark Litzow(@MRLitzow) 's Twitter Profile Photo

A lay statement from the New York Times on the unique pulmonary physiology of COVID-19. nytimes.com/2020/04/20/opi…

account_circle
Mark Litzow(@MRLitzow) 's Twitter Profile Photo

Big year for CLL at ASH 2018! Alliance-led NCTN trial shows Ibrutinib superior to BR in elderly (Plenary session) and ECOG-ACRIN-led NCTN trial shows superiority of Ibrutinib over FCR (LBA Session). And Michael Hallek is giving Ham Wasserman lecture on CLL. ASH

account_circle